Recent Study Reveals Animal-Free Expansion Media Components Eliminate Need for Blood Products in Mononuclear and Hematopoietic Stem Cells
Improving the expansion of primary cells and stems cells is a major challenge in regenerative medicine. The majority of serum-free stem cell expansion media contain undesirable animal-derived components such as plasma-derived human albumin (for nutritional support) or human transferrin (for efficient iron delivery). If these components are human blood-derived they qualify as xeno-free, however they remain a concern due to transmission risk inherent in blood products.
"Blood-derived proteins can be variable from batch-to-batch leading to inconsistencies in media performance," stated Dr. Steve Pettit, Director of Cell Culture Development at InVitria. "This study showed that Cellastim and Optiferrin allowed the cells to remain undifferentiated and continued cell growth in stem cell expansion media; another demonstration that they are superior replacements for blood-derived proteins."
The data shows that Cellastim and Optiferrin are robust components that enable the development of superior xeno-free and blood product-free expansion media.
Dr. Pettit will share the data from this study as well as other studies in stem and primary cells during an upcoming webinar on March 1st, 2011, titled, Maximizing Performance: Solutions for Stem Cells and Regenerative Medicines. All webinar registrants will receive a copy of the stem cell poster presented at the Stem Cells & Regenerative Medicine World Congress. Click here to register today.
InVitria develops, manufactures and markets a portfolio of products used in cell culture, diagnostics and bioproduction. InVitria's products address customer needs for defined, xeno-free, blood product-free and animal component-free cell culture supplements in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines and general life science research.
To obtain more information about InVitria's product solutions, e-mail info@InVitria.com or call 1-800-916-8311.
Press releases you might also be interested in
Weitere Informationen zum Thema "Biotechnik":
Unternehmen setzen auf KI und Maschine Learning
Eine von Sophos unterstütze aktuelle IDC-Studie zeigt auf, dass 70 Prozent der Unternehmen planen, dieses Jahr Künstliche Intelligenz und Machine Learning (ML) einzusetzen, um die IT-Sicherheit zu verbessern. Für die IDC-Studie wurden im letzten Quartal 108 Unternehmen mit mehr als 1.000 Mitarbeitern befragt.Weiterlesen